Your session is about to expire
← Back to Search
Mecta Spectrum 5000Q paired with Soterix Medical 4X1 HD - ECT Multi-Channel Stimulation Interface for Depression
Study Summary
This trial is looking at how to make electroconvulsive therapy (ECT) more effective and safer for older adults with depression.
- Depression
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment currently available for the research project?
"Affirmative, the research accessible on clinicaltrials.gov demonstrates that this experiment is in a state of recruitment. It was originally posted on March 1st 2021 and has been amended as recently as February 1st 2022; 40 individuals are required from one site to be enrolled in the trial."
Would I be eligible to join this experiment?
"This trial seeks to enrol 40 individuals, aged between 50 and 80 years old who are currently experiencing melancholia. To be eligible, subjects must have a diagnosis of major depressive disorder, present with symptoms necessitating electroconvulsive therapy (ECT) using right unilateral electrode placement, demonstrate being right-handedness and meet the aforementioned age criteria."
What is the current sample size of this investigation?
"Affirmative. The data hosted on clinicaltrials.gov corroborates that this medical trial is actively looking for willing individuals to join their study, which was initially published on March 1st 2021 and most recently revised January 2nd 2022. 40 volunteers are needed from a single site in order to complete the experiment."
Is eligibility for this research limited to those below a certain age?
"Per the inclusion criteria, this trial is only for people aged 50 to 80. Conversely, there are 107 trials tailored towards youngsters and 594 studies catered to seniors."
Share this study with friends
Copy Link
Messenger